계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
SymBio Pharmaceuticals
company
About
SymBio Pharmaceuticals develops therapeutic products for cancer, hematology, and autoimmune diseases.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥2B
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Mar 1, 2005
- Number Of Employee
- 51 - 100
- Operating Status
- Active
SymBio Pharmaceuticals Limited operates as a biopharmaceutical company. It offers Symbenda medicine for treating low-grade non-Hodgkin's lymphoma and chronic lymphatic leukemia in Singapore. The company was founded in 2005 and is headquartered in Tokyo, Japan.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥2.55B
SymBio Pharmaceuticals has raised a total of
¥2.55B
in funding over 2 rounds. Their latest funding was raised on
May 10, 2010 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 10, 2010 | Series Unknown | ¥550.20M | 1 | — | — | Detail |
| Jun 27, 2006 | Series B | ¥2B | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
SymBio Pharmaceuticals is funded by 2 investors.
JAFCO Group
and TNP Threads Of Light
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
TNP Threads Of Light
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
